WGS - Conference and earnings call announcements

GeneDx (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences: Canaccord Genuity 46th Annual Growth Conference Boston, MA Fireside Chat: Tuesday, August 11 at 11:00 a.m. ET Wells Fargo 21st Annual Healthcare Conference Boston, MA Fireside Chat: Tuesday, September 8 at 2:15 p.m. ET Live and archived webcasts of the presentations will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx GeneDx’s (NASDAQ:WGS) mission is to empower everyone to live their healthi

GeneDx (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference from June 8-10 in Miami, FL. Management will participate in a fireside chat on Tuesday, June 9, 2026, at 8:00 a.m. ET. A live and archived webcast of the presentation will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx GeneDx's (NASDAQ:WGS) mission is to empower everyone to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced techno

GeneDx (NASDAQ:WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences: TD Cowen 46th Annual Health Care Conference Boston, MA Fireside Chat: Monday, March 2 at 1:50 p.m. ET Barclays 28th Annual Global Healthcare Conference Miami Beach, FL Presentation: Wednesday, March 11 at 3:00 p.m. ET Live and archived webcasts of the presentations will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx GeneDx's (NASDAQ:WGS) mission is to empower everyone to live their heal

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the 44th Annual J.P. Morgan Healthcare Conference from January 12-15 in San Francisco, CA. Katherine Stueland, President and Chief Executive Officer, will participate in a presentation on Wednesday, January 14, 2026, at 3:00 p.m. PT. Live and archived webcasts will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx GeneDx (NASDAQ:WGS) is the global leader in rare disease diagnosis, with a mission to empower everyone to live their healthiest life through genom

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences: Stifel 2025 Healthcare Conference New York, New York Fireside Chat: Wednesday, November 12 at 2:00 p.m. ET Jefferies Global Healthcare Conference London, UK Presentation: Wednesday, November 19 at 11:00 a.m. GMT Piper Sandler 37th Annual Healthcare Conference New York, New York Fireside Chat: Wednesday, December 3 at 1:30 p.m. ET Live and archived webcasts of the presentations will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-ev

‘BEACONS,' a multi-state collaboration led by Mass General Brigham and Ariadne Labs, will enroll up to 30,000 newborns to explore adding genomic sequencing in U.S. newborn screening GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, alongside Mass General Brigham, Ariadne Labs, Boston Children's Hospital, Albert Einstein College of Medicine, the Association of Public Health Laboratories (APHL), Case Western Reserve University, Baylor College of Medicine, and Illumina, today announced the launch of BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening), the nation's first multi-state genomic newborn screening i

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences: Canaccord Genuity's 45th Annual Growth Conference Boston, Massachusetts Fireside chat: Tuesday, August 12 at 8:00 a.m. ET 2025 Wells Fargo Healthcare Conference Boston, Massachusetts Fireside chat: Thursday, September 4 at 2:15 p.m. ET Morgan Stanley 23rd Annual Global Healthcare Conference New York, New York Fireside chat: Monday, September 8 at 8:30 a.m. ET Live and archived webcasts of the presentations will be available on the "Events" section of the GeneDx investor relations website at ir.

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences: Jefferies Global Healthcare Conference – June 4, 2025 New York City, New York Fireside chat on Wednesday, June 4 at 9:55 a.m. ET Goldman Sachs 46th Annual Global Healthcare Conference – June 9, 2025 Miami Beach, Florida Fireside chat on Monday, June 9 at 4:00 p.m. ET Live and archived webcasts of the presentations will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (NASDAQ:WGS), we believe that everyone deserve

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the 45th Annual TD Cowen Health Care Conference from March 3-5 in Boston, MA. Management will participate in a fireside chat on Tuesday, March 4, 2025, at 1:10 p.m. ET. A live and archived webcast of the presentation will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (NASDAQ:WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare dis

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the 43rd Annual J.P. Morgan Healthcare Conference from January 12-16 in San Francisco, CA. Management will participate in a presentation on Wednesday, January 15, 2025, at 4:30 p.m. PT. Live and archived webcasts will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (NASDAQ:WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the Piper Sandler 36th Annual Healthcare Conference from December 3-5 in New York City, NY. Management will participate in a fireside chat on Tuesday, December 3, 2024, at 1:00 p.m. ET. Live and archived webcasts will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (NASDAQ:WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world's largest rare disease

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences this fall: UBS Genomic Medicine Summit – August 13-14, 2024 Dana Point, California Future of Genetic Testing - Babies and Beyond Panel on Wednesday, August 14 at 8:00 a.m. PT Morgan Stanley Healthcare Conference - September 4-6, 2024 New York, New York Wells Fargo Healthcare Conference - September 4-6, 2024 Boston, Massachusetts Fireside chat on Thursday, September 5 at 8:45 a.m. ET Jefferies London Healthcare Conference - November 19-21, 2024 London, England Live and archived webcasts of selec

STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming investor conferences in June: Jefferies Healthcare Conference - New York City, New York Fireside chat on Wednesday, June 5 at 9:00 a.m. ET44th Annual Goldman Sachs Global Healthcare Conference - Miami, Florida Fireside chat on Monday, June 10 at 3:20 p.m. ET Live and archived webcasts of the presentation will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (NASDAQ:WGS), we believe th

STAMFORD, Conn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA. Management will participate in a fireside chat on Wednesday, March 6, 2024, at 10:30 a.m. ET. A live and archived webcast of the presentation will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx At GeneDx (NASDAQ:WGS), we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosi

STAMFORD, Conn., Nov. 28, 2023 (GLOBE NEWSWIRE) -- GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate in the Evercore ISI HealthCONx Conference this week in Miami, FL. Katherine Stueland, President and Chief Executive Officer, will participate in a fireside chat on Thursday, November 30, 2023, at 10:50 a.m. ET. A live and archived webcast of the presentation will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDxGeneDx (NASDAQ:WGS) delivers personalized and actionable health insights to inform diagno

STAMFORD, Conn., May 24, 2023 (GLOBE NEWSWIRE) -- GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that management will participate at the following investor conferences in June: Jefferies Healthcare Conference Presentation on Wednesday, June 7, 2023, at 4:00 p.m. ET 44th Annual Goldman Sachs Global Healthcare Conference Fireside chat on Monday, June 12, 2023, at 12:20 p.m. ET (9:20 a.m. PT) A live and archived webcast of the presentations will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDxGeneDx (NASDAQ:WGS) delivers personalized a

STAMFORD, Conn., May 23, 2023 (GLOBE NEWSWIRE) -- GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that it will participate in multiple presentations at the World Orphan Drug Congress in Washington, D.C., May 23-25, 2023. The keynote session will highlight how GeneDx's deeply curated, 20 plus year genomic dataset combined with strong research and development experience of a biopharma partner accelerates drug development programs. Amanda Singleton, Head of Biopharma and Strategic Partnerships and Vinnie Ustach, Applied Computational Biology Lead, both from GeneDx, will be joined by Jennifer Panagoulias, Chief Regu

STAMFORD, Conn., March 01, 2023 (GLOBE NEWSWIRE) -- GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate at the Cowen 43rd Annual Healthcare Conference in Boston, MA. Katherine Stueland, President and Chief Executive Officer, will participate in a fireside chat on Tuesday, March 7, 2023, at 2:50 p.m. ET. A live and archived webcast of the presentation will be available on the "Events" section of the GeneDx investor relations website at ir.genedx.com/news-events/events. About GeneDx GeneDx, (NASDAQ:WGS) delivers personalized and actionable health insights to inform diagnosis,